SCHEMBL20398588

SCHEMBL20398588

CCCCCCC(=O)Oc1c2ccccc2c(OC(=O)CCCCCC)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.51
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
RECQL P46063 1/20 0.50
POLM Q9NP87 1/20 0.49
POLK Q9UBT6 1/20 0.49
POLL Q9UGP5 1/20 0.49
POLH Q9Y253 1/20 0.49
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
DGKA P23743 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
EP300 Q09472 1/20 0.46
ALOX15 P16050 1/20 0.46
LMNA P02545 1/20 0.44
FAAH O00519 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29371710 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL30003164 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL29370938 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL29372133 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL20398624 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL20398590 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL23271733 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL20398671 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL29368355 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL
SCHEMBL29360726 1.00 EPHX2 (0.51) EPHX2KMT2AKDM4EMEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025094874-A1 DISPERSION, CURABLE COMPOSITION, CURED PRODUCT THEREOF, AND ELECTRONIC DEVICE DIC株式会社 2025-05-08 WO disclosed
US-12065521-B2 Compound having polycyclic aromatic skeleton, and endoperoxide compound of same KAWASAKI KASEI CHEMICALS LTD. (JP) 2024-08-20 US disclosed
WO-2024075528-A1 CURABLE COMPOSITION, CURED PRODUCT THEREOF, LED ELEMENT, ELECTRONIC DEVICE, AND OPTICAL ELEMENT DIC株式会社 2024-04-11 WO disclosed
WO-2023238762-A1 METHOD FOR PRODUCING BLUE CURED FILM, BLUE PHOTOSENSITIVE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING SAME, AND DISPLAY DEVICE 株式会社DNPファインケミカル 2023-12-14 WO disclosed
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
US-20220127385-A1 COMPOUND HAVING POLYCYCLIC AROMATIC SKELETON, AND ENDOPEROXIDE COMPOUND OF SAME KAWASAKI KASEI CHEMICALS LTD. (JP) 2022-04-28 US disclosed
US-11149103-B2 Photopolymerization sensitizer composition and photopolymerizable composition comprising the same KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-10-19 US disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
US-10570227-B2 Photopolymerizable composition KAWASAKI KASEI CHEMICALS LTD. (JP) 2020-02-25 US disclosed
US-20190119426-A1 PHOTOPOLYMERIZATION SENSITIZER COMPOSITION AND PHOTOPOLYMERIZABLE COMPOSITION COMPRISING THE SAME KAWASAKI KASEI CHEMICALS LTD. (JP) 2019-04-25 US disclosed
US-20180208689-A1 PHOTOPOLYMERIZABLE COMPOSITION KAWASAKI KASEI CHEMICALS LTD. (JP) 2018-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC EPHX2 1073/4885KMT2A 2246/4885KDM4E 1028/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC EPHX2 1073/4885KMT2A 2246/4885KDM4E 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.